Modern medicine stands at a historical zenith. With the ability to detect molecular shifts before symptoms manifest, peer into the human body with high-resolution imaging, and deploy life-saving interventions in mere minutes, we live in an era of unprecedented clinical capability. Yet, this very prowess has birthed a paradoxical crisis: the healthcare system is increasingly prone to over-testing, over-diagnosing, and over-medicating.
While we celebrate the ability to do more, we are failing to ask whether we should do more. In India, this phenomenon is particularly acute, creating a bifurcated landscape where overtreatment for the affluent often exists alongside the persistent, systemic undertreatment of vulnerable populations who lack access to basic, essential primary care.
The Anatomy of the Overtreatment Cascade
Overtreatment is rarely a single, isolated event; it is a clinical cascade. It often begins with an "incidentaloma"—an abnormality detected on a scan that may never have caused harm or symptoms. This discovery triggers a diagnostic chain reaction: follow-up tests, biopsies, and eventual prescriptions. What starts as a well-intentioned health screening can inadvertently lock a patient into a lifetime of medication or invasive surgery.
This "cascade of care" is fueled by a convergence of structural, economic, and behavioral drivers that are transforming the patient-doctor relationship into a transaction-heavy marketplace.
Chronology of a Systemic Shift: How We Arrived Here
To understand the current crisis, one must look at the evolution of medical practice over the last three decades:
- The 1990s and 2000s (The Diagnostic Boom): As medical technology became more affordable and accessible, routine health check-up packages emerged as a business model. These packages often bundled unwarranted tests that produced high rates of false-positive results.
- 2012–2016 (The Global Awakening): International medical communities began recognizing the dangers of over-medicalization. The Choosing Wisely movement gained traction, prompting societies to publish lists of tests and procedures that offer little clinical value.
- 2021 (The Evidence Threshold): A systematic review published in Frontiers in Pharmacology revealed that 49% of older adults in India were experiencing polypharmacy—the simultaneous use of multiple medications.
- 2025 (The Current Crisis): New data from Scientific Reports indicates that nearly one-third of older Indian adults are on five or more prescribed medicines, with nearly 30% of these prescriptions flagged as "potentially inappropriate."
Supporting Data: The Cost of Over-Medicalization
The data paints a sobering picture of a system that has lost its focus on the "whole patient."
1. The Fragmentation of Care
The modern healthcare model in India has prioritized specialists and super-specialists, often bypassing the general physician. When a patient with a chronic condition consults four different specialists, each may focus exclusively on their specific domain. The result is "siloed" prescribing, where the body is treated in pieces rather than as an integrated biological system. This fragmentation is a primary driver of adverse drug interactions and unnecessary surgeries.
2. The Rise of Polypharmacy
Polypharmacy is not merely about taking many pills; it is about the appropriateness of those pills. When elderly patients are placed on "permanent" medication without regular reviews, the risk of falls, cognitive decline, and metabolic disruption increases exponentially. The 2025 study highlighting that 28.8% of older adults receive inappropriate medication suggests a systemic failure in routine medication management.
3. The Marketplace Influence
Medical care has increasingly morphed into a retail sector. Laboratory tests, radiological imaging, and supplements are now marketed as products. In a fee-for-service model, hospitals and diagnostic chains are financially incentivized to maximize volume. Many patients have been conditioned to believe that a consultation is only "complete" if it concludes with a prescription or a diagnostic scan, creating a feedback loop of demand and supply.
The Role of Moral Hazard in Health Insurance
Health insurance is vital for financial protection, yet it introduces unique behavioral challenges. "Ex-ante" and "ex-post" moral hazards occur when patients and providers feel encouraged to utilize expensive services simply because the insurer is footing the bill.
Crucially, this creates a false sense of security. A patient might rationalize an unnecessary, high-risk surgery by thinking, "I have paid my premiums; I should use them." What is forgotten is that while the financial cost is transferred, the biological risk—the risk of anesthesia, infection, or post-surgical complications—is borne entirely by the patient.
Defensive Medicine: The Fear Factor
Clinicians are not immune to the pressures of the modern world. In a culture of increasing litigation and high patient expectations, "defensive medicine" has become a survival strategy. If a doctor misses a rare diagnosis, they may face professional ruin; if they order an unnecessary test that yields a false positive, the system is more forgiving. Thus, the clinician chooses the "safer" route of over-testing, failing to realize that the test itself carries its own spectrum of risks.
Implications: A Call for Structural Reform
The implications of unchecked overtreatment are severe: an exhausted medical workforce, ballooning national health expenditures, and a population burdened by the side effects of unnecessary care. To reverse this trend, a multi-stakeholder approach is required.
Restoring the Primary Care Foundation
The most urgent reform is the restoration of the family physician. A general practitioner acts as the "gatekeeper" and the "navigator," ensuring that a patient only reaches a specialist when truly necessary. They are the only ones capable of conducting a holistic review of a patient’s health, reconciling conflicting medications, and deciding when "less is more."
Implementing "Choosing Wisely" in India
Professional medical bodies and the Indian Council of Medical Research (ICMR) must take the lead in developing national lists of low-value, high-risk interventions. These guidelines should be integrated into medical school curricula, hospital accreditation standards, and quality-improvement protocols. Hospitals should be evaluated not just on the volume of procedures performed, but on the capacity to avoid unnecessary ones.
Empowering the Patient
Patients must become active participants in their care. The "Choosing Wisely" campaign suggests four critical questions that every patient should ask before accepting a test or treatment:
- Why do I need this?
- What happens if I wait?
- What are the actual benefits and risks?
- Are there safer, non-invasive alternatives?
Conclusion: The Wisdom of Restraint
As Dr. Chandrakant Lahariya, author of Pill-Free, aptly notes, the future of medicine must be defined by more than just technological discovery. It must be defined by the courage of clinical restraint.
Medical progress is a virtuous path, but it is one that requires periodic recalibration. We must move toward a system that rewards clinical reasoning over volume and continuity over fragmentation. In an age of medical abundance, the most sophisticated tool a doctor can possess is not an MRI machine or a prescription pad, but the wisdom to know when to pause, observe, and protect the patient from the system itself.
Good medicine is not merely about doing things to people; it is about doing the right things, at the right time, for the right reasons. True health, in many cases, is found not in the pharmacy, but in the practice of measured, thoughtful, and evidence-based care.
